Tesla’s Optimus Robot Aims for Surgical Capabilities Amid Stock Decline

Elon Musk has unveiled ambitious plans for Tesla's Optimus humanoid robot, suggesting it could eventually perform surgical procedures. The announcement, made at a New York City event, positions the robot as a potential solution to the global shortage of skilled surgeons. Current capabilities remain limited to basic tasks like walking and lifting light objects, with an advanced version featuring improved hand mechanics expected by early 2026.

Healthcare professionals caution that the path to autonomous surgical robots will be long, requiring rigorous testing, human oversight, and the development of new regulatory frameworks. Meanwhile, Tesla's stock fell 9.18% last week amid broader tech sector sell-offs, though billionaire investor RON Baron maintains a bullish long-term outlook with a $10,000 price target within a decade.

Analysts remain divided on Tesla's prospects, with a Hold consensus rating and an average price target of $382.54—representing a 5.39% downside from current levels. The stock's recent decline reflects profit-taking in AI and tech stocks after their strong run.